Hupe MC - Search Results

1

Developing proteomic biomarkers for bladder cancer: towards clinical application.

Frantzi M, Latosinska A, Flühe L, Hupe MC, Critselis E, Kramer MW, Merseburger AS, Mischak H, Vlahou A. Frantzi M, et al. Among authors: hupe mc. Nat Rev Urol. 2015 Jun;12(6):317-30. doi: 10.1038/nrurol.2015.100. Epub 2015 May 26. Nat Rev Urol. 2015. PMID: 26032553 Review.

2

Differential expression of SDF-1 isoforms in bladder cancer.

Gosalbez M, Hupe MC, Lokeshwar SD, Yates TJ, Shields J, Veerapen MK, Merseburger AS, Rosser CJ, Soloway MS, Lokeshwar VB. Gosalbez M, et al. Among authors: hupe mc. J Urol. 2014 Jun;191(6):1899-1905. doi: 10.1016/j.juro.2013.11.053. Epub 2013 Nov 26. J Urol. 2014. PMID: 24291546 Free PMC article.

3

Preoperative and modifiable factors to lower postoperative complications after radical cystectomy.

Hupe MC, Kramer MW, Merseburger AS. Hupe MC, et al. Curr Urol Rep. 2015 Apr;16(4):19. doi: 10.1007/s11934-015-0493-y. Curr Urol Rep. 2015. PMID: 25691438 Review.

4

Successful Pregnancy and Neobladder Subsequent to Muscle Invasive Bladder Cancer and Fertility Preserving Surgery: Case Report and Review of the Literature.

Hupe MC, Merseburger AS, Günter HH, Wüstemann M, von Kaisenberg CS. Hupe MC, et al. Urol Int. 2016;96(4):488-91. doi: 10.1159/000430921. Epub 2015 May 30. Urol Int. 2016. PMID: 26044131 Review.

5

Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention.

Latosinska A, Mokou M, Makridakis M, Mullen W, Zoidakis J, Lygirou V, Frantzi M, Katafigiotis I, Stravodimos K, Hupe MC, Dobrzynski M, Kolch W, Merseburger AS, Mischak H, Roubelakis MG, Vlahou A. Latosinska A, et al. Among authors: hupe mc. Oncotarget. 2017 Apr 20;8(41):69435-69455. doi: 10.18632/oncotarget.17279. eCollection 2017 Sep 19. Oncotarget. 2017. PMID: 29050215 Free PMC article.

6

Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC).

Nicklas AP, Kramer MW, Serth J, Hennenlotter J, Hupe MC, Reimer DU, Stenzl A, Merseburger AS, Kuczyk MA, von Klot CJ. Nicklas AP, et al. Among authors: hupe mc. Adv Ther. 2018 Nov;35(11):2054-2068. doi: 10.1007/s12325-018-0789-7. Epub 2018 Sep 19. Adv Ther. 2018. PMID: 30232708 Free PMC article.

7

Omics Derived Biomarkers and Novel Drug Targets for Improved Intervention in Advanced Prostate Cancer.

Frantzi M, Hupe MC, Merseburger AS, Schanstra JP, Mischak H, Latosinska A. Frantzi M, et al. Among authors: hupe mc. Diagnostics (Basel). 2020 Aug 31;10(9):658. doi: 10.3390/diagnostics10090658. Diagnostics (Basel). 2020. PMID: 32878288 Free PMC article. Review.

8

Advanced prostate cancer.

Hupe MC, Merseburger AS. Hupe MC, et al. World J Urol. 2021 Feb;39(2):295-296. doi: 10.1007/s00345-021-03618-4. World J Urol. 2021. PMID: 33591380 No abstract available.

9

[Diagnostic markers in urology].

Hupe MC, Hempel MC, Rodler S, Frantzi M, Mischak H, Merseburger AS, Stief CG, Chaloupka M. Hupe MC, et al. Urologe A. 2021 Oct;60(10):1323-1330. doi: 10.1007/s00120-021-01568-8. Urologe A. 2021. PMID: 34156515 Review. German.

10

[Neoadjuvant or Adjuvant Chemotherapy for Bladder Cancer?].

Hupe MC, Kramer MW, Kuczyk MA, Merseburger AS. Hupe MC, et al. Aktuelle Urol. 2015 May;46(3):242-7. doi: 10.1055/s-0035-1549948. Epub 2015 Jun 12. Aktuelle Urol. 2015. PMID: 26077309 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page